Document Classification

Section Type: METHODS

Text: Helicobacter pylori-positive patients (n = 323) with non-ulcer dyspepsia were randomized to receive one of four 1-week regimens consisting of omeprazole, 20 mg b. d., plus either : amoxicillin, 1000 mg b. d., and clarithromycin, 500 mg b. d. (OAC) ; bacampicillin, 1200 mg b. d., and clarithromycin, 500 mg b. d. (OBC) ; clarithromycin, 250 mg b. d., and metronidazole, 500 mg b. d. (OCM) ; or amoxicillin, 1000 mg b. d, and azithromycin, 500 mg on day 1 and 250 mg on days 2-5 (OAAz).